Introduction
============

The Lack's circuit (or modified co-axial Mapleson A breathing system) is commonly used in spontaneously breathing anesthetized adults. It does not contain a carbon dioxide absorber; thus, its performance relies on an adequate fresh gas flow (FGF) to prevent rebreathing.[@b1-mder-9-395] The Lack's circuit is the most efficient and economical system for spontaneous respiration in adults compared to the Magill's and Bain's circuits.[@b1-mder-9-395] It is compact, lightweight and portable, with additional convenient access to the exhaust (adjustable pressure limiting or APL valve), easy scavenging of polluting gases, and low expiratory resistance.

According to the philosophy on sustainable economics of Thailand's sovereign (His Majesty King Bhumibol), "Understanding, Accessibility and Development" represent the three rings for success. We thus invented the modified Lack's circuit for use in adult patients -- aka the Lack-Plus circuit -- using inexpensive and readily available materials in the operating room.[@b2-mder-9-395]

The difference between the Lack and Lack-Plus circuits is that the Lack-Plus circuit has an additional intraluminal one-way valve on the inner expiratory tube situated proximal to the APL valve, which minimizes FGF, saves anesthetic gas, and decreases operating room pollution. The components include a 100 mL normal saline solution plastic bottle; a rubber glove; 1, 3, 10, and 20 mL plastic syringes; a 22 mm internal diameter corrugated tube (outer reservoir tube); a 10 mm internal diameter hollow plastic tube (inner exhaust tube); a yellow hollow latex rubber tubes with connector for FGF outlet; and a 22 mm internal diameter three-way plastic connector ([Figure 1](#f1-mder-9-395){ref-type="fig"}).

Objectives
==========

The aim of this clinical trial was to compare the Lack-Plus and Lack's circuit vis-à-vis minimal FGF requirements with no rebreathing in spontaneously breathing anesthetized adults.

Materials and methods
=====================

The Institutional Review Board of Khon Kaen University (KKU) approved the study (HE571249). All the patients provided written informed consent.

The current study was conducted at Srinagarind Hospital, Faculty of Medicine, KKU, Khon Kaen, Thailand. Between September and October 2014, 24 patients aged between 18 and 60 years with an American Society of Anesthesiologists (ASA) physical status I--II and body mass index (BMI) ≤30 kg/m^2^, scheduled for elective peripheral surgery in supine position under general anesthesia, were included in a randomized crossover study. Patients were excluded if they had a body temperature \>37.8°C, a respiratory disease (COPD, asthma, chronic bronchitis), a cardiovascular disease, a contraindication to succinylcholine, or they refused surgery.

Immediately after the patients entered the operating room, eligible patients were randomly assigned to one of the following two arms: LP-L: the Lack-Plus circuit was used first and then switched to the Lack's circuit orL-LP: the Lack's circuit was used first and then switched to the Lack-Plus circuit

The multi-gas monitor used in this study was Philips IntelliVue MP30 with M1013A module (Philips Medizin-Systeme Böblingen GmbH, Böblingen, Germany).

All the patients were given diazepam 0.1--0.2 mg/kg and paracetamol 10--15 mg/kg orally 1 h before transferring to the operating room. Baseline blood pressure, pulse, and oxygen saturation (SpO~2~) were obtained by standard monitors. Anesthesia was induced with fentanyl 1--2 µg/kg and propofol 2--2.5 mg/kg IV. Then, each patient was intubated using succinylcholine 1--1.5 mg/kg IV. Anesthesia was maintained with FGF containing 50% N~2~O/O~2~ in combination with desflurane 4%--6%, adjusted to 1--1.2 MAC anesthetic level to maintain normal vital signs. Fentanyl was titrated to ensure an optimal respiratory rate (RR; range, 10--16/min). All the patients were spontaneously breathing with FGF 4 L/min at the start of each anesthetic breathing circuit. The authors waited for the depth of surgical anesthesia to be maintained for at least 10 min. The baseline end-tidal carbon dioxide (ETCO~2~), inspired minimum carbon dioxide (ImCO~2~), RR, mean arterial pressure (MAP), and SpO~2~ were measured.

The amount of FGF was reduced step-by-step by 0.5 L/min every 5 min, waiting for ImCO~2~ to be regularly maintained for at least 60 sec; then ETCO~2~, ImCO~2~, RR, MAP, and SpO~2~ values were recorded at each step until rebreathing occurred (ImCO~2~ \>0). FGF was then reduced to 2.5 L/min and ImCO~2~ was recorded.

The anesthetic breathing circuit was switched over. The FGF was switched back to 4 L/min for 10 min, after which the procedure was repeated. The minimal FGF before rebreathing occurred and the ImCO~2~ at a FGF of 2.5 L/min were recorded.

All intraoperative and postoperative complications were observed and recorded. The study flow is presented in [Figure 2](#f2-mder-9-395){ref-type="fig"}.

Statistical analysis
--------------------

A minimum of 20 patients were needed to detect a clinically relevant reduction in FGF of 20%, with a power of 0.90 and a level of significance of 5%. Twenty-four patients were recruited to cover a potential dropout rate of 20%. Randomization was achieved using a computer-generated list (kept in sealed envelopes). Statistical analyses were performed with Statistical Package for the Social Sciences (SPSS) for Windows version 17.0 (SPSS Inc., Chicago, IL, USA). Continuous data were expressed as mean±SD and compared using the paired Student's *t*-test or Mann-Whitney *U* test where applicable. Categorical data were expressed by number (%), and comparison was made by chi-square test. A *p*-value \<0.05 was considered statistically significant.

Results
=======

Twenty-four patients fulfilled the entry criteria and were enrolled in the study. Both groups (LP-L and L-LP) were comparable with respect to age, sex, BMI, ASA physical status, and type of operation ([Table 1](#t1-mder-9-395){ref-type="table"}).

Primary outcome
---------------

The mean minimal FGF at the point of rebreathing was significantly lower in the Lack-Plus group than in the Lack group (*p*\<0.001) ([Table 2](#t2-mder-9-395){ref-type="table"}). The ETCO~2~ level was significantly higher in the Lack-Plus group, and the FGF requirement was decreased by 18.7% for no rebreathing. The mean RR, arterial pressure, and SpO~2~ value between the groups were not significantly different.

Secondary outcome
-----------------

The mean ImCO~2~ at the FGF of 2.5 L/min was significantly lower in the Lack-Plus group than in the Lack group (*p*\<0.001) ([Table 3](#t3-mder-9-395){ref-type="table"}). There was no statistically significant difference between the groups vis-à-vis ETCO~2~, MAP, and SpO~2~. The RR was statistically different but was within normal clinical range (11.8 and 11.2 tpm). No incidence of complications was observed during perioperative period.

Discussion
==========

Among non-absorber anesthetic breathing circuits, the Magill's, Lack's, and Bain's circuits are commonly used during general anesthesia for spontaneous respiration in adult patients. Humphrey[@b1-mder-9-395] demonstrated that the Lack's circuit had the lowest ImCO~2~ and ETCO~2~ compared to the Magill's and Bain's circuits, by using a FGF of 70 mL/kg/min. Additionally, the respective FGF requirement in the Lack's, Magill's, and Bain's circuits that caused rebreathing was 51, 73, and 153 mL/kg/min, respectively. The Lack's circuit, therefore, appears superior in performance to the Magill's and Bain's circuits for spontaneous respiration in adults, economical use of FGF, convenient exhaust valve, and easy scavenging facilities.

The Lack-Plus circuit -- a modification of the Lack's -- was invented by Theerapongpakdee[@b2-mder-9-395],[@b3-mder-9-395] for spontaneous breathing anesthesia in adults. Theerapongpakdee devised the Lack-Plus circuit using materials readily available in the operating room ([Figure 1](#f1-mder-9-395){ref-type="fig"}).

The intraluminal one-way valve -- situated on the expiratory limb of the non-absorber breathing system -- was used in the new enclosed anesthetic circuit such as the enclosed afferent reservoir (EAR),[@b4-mder-9-395] baby EAR,[@b5-mder-9-395],[@b6-mder-9-395] and displacement afferent reservoir (DAR) systems. The advantage of such a position was more effective prevention of rebreathing during the inspiration phase.

Our hypothesis is that the Lack-Plus circuit -- with the addition of an intraluminal one-way valve -- would be more efficient than the Lack's circuit in that it requires less FGF to prevent rebreathing, reduces loss of heat and humidity, and causes less pollution in the operating room.

The minimal FGF at the point of rebreathing for the Lack-Plus circuit in the current report was significantly less than for the Lack's circuit (2.7±0.8 and 3.3±0.5 L/min, respectively, *p*\<0.001). This result agrees with Kain and Nunn[@b8-mder-9-395],[@b9-mder-9-395] who demonstrated that the minimal adequate FGF to prevent rebreathing of the Magill's circuit was 3.1--4.6 L/min. At a FGF of 2.5 L/min, the ImCO~2~ of the Lack-Plus circuit was significantly lower than the Lack's circuit (1.5±2.0 and 4.2±2.6 mmHg respectively, *p*\<0.001), demonstrating that the intraluminal one-way valve situated proximal to the APL valve effectively helps to prevent rebreathing.

ETCO~2~ at the point of rebreathing in both the groups was statistically significant different. Notwithstanding, there were no significant differences in clinical practice owing to the ETCO~2~ value of both the systems, which were within the normal, clinical, acceptable range (46.9±7.9 and 44.8±8.1 mmHg, respectively, *p*=0.025).

Limitations of the study
------------------------

Since we reduced FGF at a step of 0.5 L/min, it might be not absolutely accurate to detect the actual FGF at each end point of the study.

Conclusion
==========

The Lack-Plus circuit is a modified Lack's circuit (i.e., a modified co-axial Mapleson A), which is a non-carbon dioxide absorber anesthetic circuit with an additional intra-luminal one-way valve and a gas scavenging port. It can be used safely, effectively, and requires less FGF than the Lack's circuit in spontaneously breathing anesthetized adults (BMI ≤30 kg/m^2^). The optimal FGF requirement for the Lack-Plus circuit to prevent rebreathing is 2.7±0.8 L/min.
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![Lack-Plus circuit: actual circuit (**A**) and diagram (**B**).\
**Abbreviations:** B, breathing reservoir bag; E, inner exhaust tube; F, fresh gas inlet; OV, intraluminal one-way valve; P, patient; R, outer reservoir tube; S, scavenging system; V, syringe expiratory valve.](mder-9-395Fig1){#f1-mder-9-395}

![CONSORT flow diagram of the study.\
**Abbreviations:** LP-L, Lack-Plus followed by Lack's circuit; L-LP, Lack's followed by Lack-Plus circuit; LP, Lack-Plus group; L, Lack group; CONSORT, Consolidated Standards of Reporting Trials.](mder-9-395Fig2){#f2-mder-9-395}

###### 

Demographic and clinical data of the patients in the LP-L and L-LP groups

  -----------------------------------------------------------
  Variables               LP-L\       L-LP\       *p*-value
                          (n=12)      (n=12)      
  ----------------------- ----------- ----------- -----------
  Age (year)              38.5±13.9   36.5±15.2   0.741

  Sex: male               8 (66.7)    4 (33.3)    0.102

  BMI (kg/m^2^)           23.6±3.3    22.3±2.7    0.301

  Body temperature (°C)   36.9±0.5    36.8±0.5    0.990

  ASA classification                              

   I                      8 (66.7)    9 (75)      0.653

   II                     4 (33.3)    3 (25)      

  Operation                                       

   Orthopedics            3 (25)      2 (16.7)    0.879

   ENT                    8 (66.7)    9 (75)      

   Plastic                1 (8.3)     1 (8.3)     
  -----------------------------------------------------------

**Note:** Values are presented as mean±SD or number (%).

**Abbreviations:** LP-L, Lack-Plus followed by Lack's circuit; L-LP, Lack's followed by Lack-Plus circuit; BMI, body mass index; ASA, American Society of Anesthesiologists; ENT, ear, nose, throat; SD, standard deviation.

###### 

FGF, ETCO~2~, RR, MAP, and SpO~2~ at point of rebreathing (ImCO~2~ \>0 mmHg)

  ------------------------------------------------------------------------------------
  Variables        L\          LP\        Mean difference   95% CI         *p*-value
                   (n=24)      (n=24)                                      
  ---------------- ----------- ---------- ----------------- -------------- -----------
  FGF (L/min)      3.3±0.5     2.7±0.8    −0.63             −0.86, −0.40   \<0.001

  ETCO~2~ (mmHg)   44.8±8.1    46.9±7.9   2.09              0.29, 3.89     0.025

  RR (tpm)         11.9±1.6    11.5±1.2   −0.36             −1.10, 0.38    0.321

  MAP (mmHg)       72.9±11.3   73.4±8.0   0.50              −2.79, 3.79    0.755

  SpO~2~ (%)       99.2±1.4    99.2±1.3   0.00              −0.13, 0.13    1.000
  ------------------------------------------------------------------------------------

**Note:** Values are presented as mean±SD.

**Abbreviations:** FGF, fresh gas flow; ETCO~2~, end-tidal carbon dioxide; RR, respiratory rate; MAP, mean arterial pressure; SpO~2~, oxygen saturation; ImCO~2~, inspired minimum carbon dioxide; L, Lack group; LP, Lack-Plus group; CI, confidence interval; SD, standard deviation.

###### 

ImCO~2~, ETCO~2~, RR, MAP, and SpO~2~ at FGF 2.5 L/min

  -------------------------------------------------------------------------------------
  Variables        L\          LP\         Mean difference   95% CI         *p*-value
                   (n=24)      (n=24)                                       
  ---------------- ----------- ----------- ----------------- -------------- -----------
  ImCO~2~ (mmHg)   4.2±2.6     1.5±2.0     −2.68             −3.60, −1.76   \<0.001

  ETCO~2~ (mmHg)   46.5±8.4    47.0±7.8    0.50              −1.02, 2.02    0.504

  RR (tpm)         11.8±1.3    11.2±1.3    −0.63             −1.22, −0.04   0.036

  MAP (mmHg)       76.2±11.9   72.3±10.1   −3.86             −8.21, 0.48    0.079

  SpO~2~ (%)       99.4±1.1    99.4±1.1    0.00              −0.23, 0.23    1.000
  -------------------------------------------------------------------------------------

**Note:** Values are presented as mean±SD.

**Abbreviations:** ImCO~2~, inspired minimum carbon dioxide; ETCO~2~, end-tidal carbon dioxide; RR, respiratory rate; MAP, mean arterial pressure; SpO~2~, oxygen saturation; FGF, fresh gas flow; L, Lack group; LP, Lack-Plus group; CI, confidence interval; SD, standard deviation.
